Commentary

Tim Quast
Traders Magazine Online News

We're All HFTs Now

In this guest commentary, author Tim Quast looks back at the history of HFT and how the market has evolved to where many firms now fit the definition of high-frequency trader.

Traders Poll

Are you in favor of a pilot program and examination of the rebate system by the SEC?




Free Site Registration

April 20, 2010

New Book on Algos Earmarks Profits for Cancer Charity

By John D'Antona Jr.

When Barry Johnson began writing his 598-page tome "Algorithmic Trading & DMA" in 2006, it was going to be a beginner's guide.

Then everything changed in 2008.

Johnson showed his draft to trading professionals who said the book was a more thorough text than a primer. Concurrently, his mother, Margaret, was diagnosed with multiple myeloma, a cancer that affects the plasma cells, which are responsible for antibody production.

So Johnson forged on and continued research on his book, while at the same time learning more about the incurable form of cancer his mother faced.

"I wanted to learn more about market microstructure and how to apply it for trading rules and ended up writing this book," Johnson said. "One of the aims of the book is to try and marry all the various research studies that have been carried out with the practice of execution."

The book explains algorithmic trading from the ground up, moving from market basics to order types and then to execution algorithms like volume-weighted average pricing and implementation shortfall. Later chapters, not included in the original manuscript, cover portfolio and multi-asset trading, data mining and artificial intelligence.

The book is dedicated to Johnson's mother, as you might expect, and self-published by 4Myeloma Press. "Algorithmic Trading & DMA" is available for $39.20 at Amazon.com. Net proceeds are earmarked for the charity Myeloma UK.

 

(c) 2010 Traders Magazine and SourceMedia, Inc. All Rights Reserved.

http://www.tradersmagazine.com http://www.sourcemedia.com/